MassChallenge Startups Create Impact

2,458

Startups Accelerated

$6.2B

Funding Raised

$3B

Revenue Generated

157,000+

Jobs Created

Our startups

Be inspired. Search our startups.

Clear  
LIfT BioSciences

LIfT Biosciences is a socially-minded Biotech start-up commercialising Leukocyte Infusion Therapy (LiFT), building on 18 years of ground breaking research. LIfT BioSciences has a patent pending technology platform for developing the World’s first and only Cell Bank of Cancer Killing Neutrophils for all solid tumours. Our first mission is to have Developed a Cure for Pancreatic Cancer by 2021. We have successfully cultured The World’s 1st Cancer Killing Neutrophils and completed SEED funding.
A socially-minded Biotech start-up creating The World's First Cell Bank of Cancer Killing Innate Immune Cells to cure a range of cancers.

Connect with LIfT BioSciences

LIfT BioSciences

2018

2018 Finalist Switzerland

Sub industry

Therapeutics (Pharma / Biotech)

Mission

MassChallenge strengthens the global innovation ecosystem by accelerating high-potential startups across all industries, from anywhere in the world.